Correction - Block Listing Update

RNS Number : 2276Q
Futura Medical PLC
25 November 2016
 

The following amendment has been made to the Block Listing Update announcement released on 25 November 2016 at 15:05 under RNS No 2178Q.

The balance under the scheme(s) of securities not yet issued at the end of the period has been corrected to 2,520,462.

All other details remain unchanged. The full amended text is shown below.

 

 

 


25 November 2016

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Block Listing Update

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology makes the following amended update on its block listing, pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies. All figures relate to options over ordinary shares of 0.2 pence each.

The table below provides further detail.

 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")

EMI Share Option Scheme ("EMI")

Period of return:

From:

20 May 2016

To:

24 November 2016

Number and class of securities not issued under the scheme(s)

USOS:

1,440,600

EMI:

1,344,141

Total:

2,784,741

 

Number of securities issued under the scheme(s) during the period

 

 

Number of securities lapsed under the scheme(s) during the period (EMI adjustment to May return)

USOS:

Nil

EMI:

 

 

USOS:

EMI:

 

Nil

 

 

(284,279)

   20,000

 

Balance under the scheme(s) of securities not yet issued at the end of the period (EMI adjustment to May return)

USOS:

1,156,321

EMI:

1,364,141

Total:

2,520,462

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

USOS Total:

2,016,704



EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

EMI Total:

2,988,296




Total:

5,005,000

 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

 

 

For further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

 

N+1 Singer (Nominated Adviser and Broker)

 

Aubrey Powell / Liz Yong

Corporate Finance

 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

 

Buchanan

 

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRAKPDDOBDDADB
UK 100

Latest directors dealings